Deloitte leaders discuss Medtech industry trends, challenges, and opportunities in a changing health care marketplace
Rapid health care market changes are challenging Medtech industry stakeholders to evolve and expand their current product supplier role to thrive in the Future of Health. In this series, Deloitte leaders share how Medtech companies can advance clinical, commercial, and digital transformation.
The health care industry is dramatically shifting. Exponential innovation by Medtech companies is needed, so they can compete in the world of digitally driven health care. Explore the lessons learned from exponential innovation leaders.
The potential for digital surgeries is generating excitement and investment throughout the healthcare ecosystem. Explore the three possible future vectors for digital surgery that have the potential to improve clinical outcomes, efficiency, and cost-effectiveness of care episodes requiring a surgical intervention.
The future of 5G is already here! Medtech R&D teams should have already thought through the various implications and use cases leveraging 5G. Those that haven’t started on this path are likely already trailing their competitors. Explore how 5G and edge computing could enhance medical devices and health care services reliant on devices.
The pandemic continues to shine a spotlight on how medtech is critical to our nation’s healthcare infrastructure and our ability to respond to extraordinary events. It is time to harness that momentum and take advantage of the opportunities that lie ahead. Deloitte’s Glenn Snyder discusses these opportunities, and 6 trends that organizations can expect in 2022.
The context of health care and its delivery is transitioning to focus on the patient/user, providing opportunities for Medtech companies to expand the marketplace for their products. To thrive under this new context, companies will need to incorporate digitally enabled consumer engagement capabilities into their product design. The preferred path forward is to launch a separate business venture that is underpinned by a growth- and transformation-oriented mindset.
Medtech companies that want to evolve beyond their traditional product supplier role to become a value-driven, strategic business partner to their hospital customers will need to undergo a multifaceted transformation that addresses six success factors.
The health care ecosystem is undergoing unprecedented changes, compelling Medtech manufacturers to rethink traditional commercial models. At the heart of commercial transformation is moving from “doing digital”—applying digital capabilities in an ad hoc manner—to “being digital”—designing and implementing a differentiating digital strategy.
Medical device manufacturers have been talking about the transition to value-based care (VBC) for much of the past decade. Yet, despite many executive-level conversations, stacks of white papers, and countless conference sessions, VBC contracting in Medtech remains largely stuck in the mud, even as it gains traction in the broader health sector.